Literature DB >> 25234603

The benefit of tissue contact monitoring with an electrical coupling index during ablation of typical atrial flutter--a prospective randomised control trial.

Michael A Jones1, David Webster, Kelvin C K Wong, Christopher Hayes, Norman Qureshi, Kim Rajappan, Yaver Bashir, Timothy R Betts.   

Abstract

INTRODUCTION: We sought to investigate the use of tissue contact monitoring by means of the electrical coupling index (ECI) in a prospective randomised control trial of patients undergoing cavotricuspid isthmus (CTI) ablation for atrial flutter.
METHODS: Patients with ECG-documented typical flutter undergoing their first CTI ablation were randomised to ECI™-guided or non-ECI™-guided ablation. An irrigated-tip ablation catheter was used in all cases. Consecutive 50-W, 60-s radiofrequency lesions were applied to the CTI, from the tricuspid valve to inferior vena cava, with no catheter movement permitted during radiofrequency (RF) delivery. The ablation endpoint was durable CTI block at 20 min post-ablation. Patients underwent routine clinic follow-up post-operatively.
RESULTS: A total of 101 patients (79 male), mean age 66 (+/-11), 50 ECI-guided and 51 control cases were enrolled in the study. CTI block was achieved in all. There were no acute complications. All patients were alive at follow-up. CTI block was achieved in a single pass in 36 ECI-guided and 30 control cases (p = 0.16), and at 20 min post-ablation, re-conduction was seen in 5 and 12 cases, respectively (p = 0.07). There was no significant difference in total procedure time (62.7 ± 33 vs. 62.3 ± 33 min, p = 0.92), RF requirement (580 ± 312 vs. 574 ± 287 s, p = 0.11) or fluoroscopy time (718 ± 577 vs. 721 ± 583 s, p = 0.78). After 6 ± 4 months, recurrence of flutter had occurred in 1 (2 %) ECI vs. 8 (16 %) control cases (OR 0.13, 95 % CI 0.01-1.08, p = 0.06).
CONCLUSIONS: ECI-guided CTI ablation demonstrated a non-statistically significant reduction in late recurrence of atrial flutter, at no cost to procedural time, radiation exposure or RF requirement.

Entities:  

Mesh:

Year:  2014        PMID: 25234603     DOI: 10.1007/s10840-014-9943-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  19 in total

1.  Contact sensing provides a highly accurate means to titrate radiofrequency ablation lesion depth.

Authors:  Douglas Holmes; Jeffrey M Fish; Israel A Byrd; Jeremy D Dando; Steven J Fowler; Hong Cao; James A Jensen; Harry A Puryear; Larry A Chinitz
Journal:  J Cardiovasc Electrophysiol       Date:  2010-11-29

2.  The effects of electrode-tissue contact on radiofrequency lesion generation.

Authors:  B Avitall; K Mughal; J Hare; R Helms; D Krum
Journal:  Pacing Clin Electrophysiol       Date:  1997-12       Impact factor: 1.976

3.  Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study.

Authors:  Petr Neuzil; Vivek Y Reddy; Josef Kautzner; Jan Petru; Dan Wichterle; Dipen Shah; Hendrik Lambert; Aude Yulzari; Erik Wissner; Karl-Heinz Kuck
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-03-20

4.  Use of electrical coupling information in AF catheter ablation: a prospective randomized pilot study.

Authors:  Thomas Gaspar; Haris Sih; Gerhard Hindricks; Charlotte Eitel; Philipp Sommer; Simon Kircher; Sascha Rolf; Arash Arya; Liane Teplitsky; Christopher Piorkowski
Journal:  Heart Rhythm       Date:  2012-10-09       Impact factor: 6.343

5.  The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study.

Authors:  Vivek Y Reddy; Dipen Shah; Josef Kautzner; Boris Schmidt; Nadir Saoudi; Claudia Herrera; Pierre Jaïs; Gerhard Hindricks; Petr Peichl; Aude Yulzari; Hendrik Lambert; Petr Neuzil; Andrea Natale; Karl-Heinz Kuck
Journal:  Heart Rhythm       Date:  2012-07-20       Impact factor: 6.343

Review 6.  Meta-analysis of ablation of atrial flutter and supraventricular tachycardia.

Authors:  Peter Spector; Matthew R Reynolds; Hugh Calkins; Manu Sondhi; Yingxin Xu; Amber Martin; Catherine J Williams; Isabella Sledge
Journal:  Am J Cardiol       Date:  2009-09-01       Impact factor: 2.778

7.  Contact force sensing technology identifies sites of inadequate contact and reduces acute pulmonary vein reconnection: a prospective case control study.

Authors:  Shouvik Haldar; Julian W E Jarman; Sandeep Panikker; David G Jones; Tushar Salukhe; Dhiraj Gupta; Gareth Wynn; Wajid Hussain; Vias Markides; Tom Wong
Journal:  Int J Cardiol       Date:  2012-12-04       Impact factor: 4.164

8.  Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis.

Authors:  Francisco J Pérez; Christine M Schubert; Babar Parvez; Vishesh Pathak; Kenneth A Ellenbogen; Mark A Wood
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-06-23

9.  Catheter-tissue contact force for pulmonary veins isolation: a pilot multicentre study on effect on procedure and fluoroscopy time.

Authors:  Giuseppe Stabile; Francesco Solimene; Leonardo Calò; Matteo Anselmino; Antonello Castro; Claudio Pratola; Paolo Golia; Nicola Bottoni; Giuseppe Grandinetti; Antonio De Simone; Roberto De Ponti; Serena Dottori; Emanuele Bertaglia
Journal:  Europace       Date:  2013-12-12       Impact factor: 5.214

10.  Long term outcome of cavotricuspid isthmus cryoablation for the treatment of common atrial flutter in 180 patients: a single center experience.

Authors:  Wendel Moreira; Carl Timmermans; Hein J J Wellens; Yuka Mizusawa; David Perez; Suzanne Philippens; Luz-Maria Rodriguez
Journal:  J Interv Card Electrophysiol       Date:  2008-01-31       Impact factor: 1.900

View more
  1 in total

1.  Use of impedance-based catheter tip-to-tissue contact assessment (electroanatomic coupling index, ECI) in typical right atrial flutter ablation.

Authors:  Massimiliano Maines; Francesco Peruzza; Alessandro Zorzi; Domenico Catanzariti; Carlo Angheben; Maurizio Del Greco
Journal:  J Interv Card Electrophysiol       Date:  2018-04-21       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.